Skip to content
Disclosery

Empyrean Capital Partners, LP: CVS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Empyrean Capital Partners, LP on CVS, newest first. How the timeline and the estimate are built.

Empyrean Capital Partners, LP held 0 CVS shares at 2026-03-31 per its 13F-HR filed 2026-05-15.

the latest 13F is the newest step

  1. period ended2026-03-31
    13F 0 shares
    Change vs previous 13F -1,160,000 shares

    13F-HR 0001317195-26-000002 filed by Empyrean Capital Partners, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-12-31
    13F 1,160,000 shares
    Change vs previous 13F +117,500 shares

    3.21% of the 13F portfolio, value $92,057,600.

    13F-HR 0001317195-26-000001 filed by Empyrean Capital Partners, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-09-30
    13F 1,042,500 shares
    Change vs previous 13F +180,500 shares

    3.15% of the 13F portfolio, value $78,594,075.

    13F-HR 0001317195-25-000009 filed by Empyrean Capital Partners, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-06-30
    13F 862,000 shares
    Change vs previous 13F -669,000 shares

    2.75% of the 13F portfolio, value $59,460,760.

    13F-HR 0001085146-25-005272 filed by Empyrean Capital Partners, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-03-31
    13F 1,531,000 shares
    Change vs previous 13F +641,000 shares

    5.55% of the 13F portfolio, value $103,725,250.

    13F-HR 0001085146-25-003352 filed by Empyrean Capital Partners, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2024-12-31
    13F 890,000 shares
    Change vs previous 13F not available

    2.01% of the 13F portfolio, value $39,952,100.

    13F-HR 0001085146-25-001651 filed by Empyrean Capital Partners, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).